pharma · Calculus, Dental · Oral Malodor
Colgate Oral Pharmaceuticals
Colgate Oral Care
Colgate Oral Care is a pharma organization headquartered in AU. Primary therapeutic focus areas include Calculus, Dental, Oral Malodor. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s
Company details
- Status
- Public
- HQ
- AU
- Programs
- 2
- Drugs
- 0
- Patents
- 0
Quick answer
Colgate Oral Care is a pharma organization headquartered in AU. Primary therapeutic focus areas include Calculus, Dental, Oral Malodor. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (2).
Company snapshot
https://onlinecareer360.com/
- 2 active pipeline program(s) linked via ClinicalTrials.gov.
- 2 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Colgate Oral Pharmaceuticals. Not investment advice.
Top assets
Lead pipeline drugs
- Phase 3
- Phase 3
Active clinical programs
- Phase 3
- Phase 3
Momentum signals
Momentum
Proprietary activity score for Colgate Oral Pharmaceuticals.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitive landscape
Recent activity
Recent activity
Latest pipeline, patent, and corporate events for Colgate Oral Pharmaceuticals.
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Colgate Oral Pharmaceuticals?
-
Is Colgate Oral Pharmaceuticals publicly traded?
-
What drugs does Colgate Oral Pharmaceuticals develop or market?
-
What are the latest developments for Colgate Oral Pharmaceuticals?
-
What therapeutic areas does Colgate Oral Pharmaceuticals focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.